Identification of an EGCG oxidation derivative with proteasome modulatory activity.
(-)-epigallocatechin-3-gallate (EGCG) has been shown to possess chemopreventative properties and the ability to inhibit proteasome, a multicatalytic protease involved in the removal of oxidized and misfolded proteins and in the turnover of important checkpoint proteins. The stability of EGCG under neutral-alkaline and cellular physiological conditions was evaluated, identifying a biologically active ring-fission oxidative product. This derivative differentially affected proteasome activities with respect to EGCG in vitro, whereas, in cervical carcinoma cells, both compounds inhibited proteasome functionality to a similar extent, promoting a significant accumulation of ubiquitinated proteins and apoptotic markers. Despite of EGCG high instability, an equally active metabolite, able to modulate both proteasome functionality and apoptotic pathways, is generated. Interestingly this derivative protracts both the EGCG antioxidant and proteasome modulating efficacy, irrespective of the catechin short half-life.